Biotechnology finance leader with both large & small company experience, supporting multiple therapeutic areas including Nephrology, Inflammation, Cardiology, Ophthalmology, & Hematology. Particular experience partnering with commercial/customer-facing organizations, having worked on multiple product launches, including rare disease & biosimilars, as well as established blockbuster brands across a wide variety of distribution & reimbursement environments. I bring expertise translating the overall needs of the organization & their place in it to my business partners, as well as simplifying complexity to deliver the so-what to the C-suite.Specialties include: corporate finance, financial modelling, P&L Management, commercialization, product launches, competitive analysis & strategy, gross-to-net, revenue & supply forecasting, budget & long-range planning, contracting analytics, valuation, international expansion, integration, revenue recognition, inventory & channel management, cross-functional project management.